STOCKHOLDERS' EQUITY (Tables)

6 Months Ended

Jun. 30, 2026

STOCKHOLDERS' EQUITY

Schedule of stock option activity


						Weighted
				Weighted		average
				average		remaining		Aggregate
				exercise		contractual		Intrinsic
		Number of		price		life		value
		options**		$		Years		$
Options outstanding at beginning of period		336,768		46.21		8.16		4
Options granted		23,150		9.10		—		—
Options exercised		—		—		—		—
Options expired		(50,454)		61.02		—		—
Options forfeited		(11,413)		15.36		—		—

Options outstanding at end of period		298,051		42.00		8.10		0

Options vested and expected to vest at end of period		221,651		40.01		8.06		—

Exercisable at end of period		145,074		63.43		7.59		0

(**) See note 1e regarding reverse share split.

Schedule of restricted stock option activity


						Number of
						Restricted shares**

Restricted shares outstanding at beginning of year						613,465
Restricted shares granted						25,127
Restricted shares forfeited						(3,499)

Restricted shares outstanding at end of period						635,093

(**) See note 1e regarding reverse share split.

Schedule of assumptions used to estimate the fair values of the options granted to employees, directors and non-employees


		Six months ended
		June 30,
		2026		2025
Volatility		97.64-101.10	%	96.72-102.19	%
Risk-free interest rate		3.79-4.09	%	4.08-4.23	%
Dividend yield		—	%	—	%
Expected life (years)		5.81-5.88		5.00-5.87

Schedule of compensation cost


		Three months ended
		June 30,
		2026			2025
Cost of revenues		$	2		$	6
Research and development			(134)			441
Sales and marketing			308			583
General and administrative			456			1,005

Total stock-based compensation expenses		$	632		$	2,035


		Six months ended
		June 30,
		2026			2025
Cost of revenues		$	7		$	16
Research and development			(42)			966
Sales and marketing			441			1,398
General and administrative			1,667			1,997

Total stock-based compensation expenses		$	2,073		$	4,377